Bio Green Med Solution, Inc. (BGMS) vs PharmaCyte Biotech, Inc. (PMCB)
A side-by-side comparison of Bio Green Med Solution, Inc. and PharmaCyte Biotech, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BGMS
Bio Green Med Solution, Inc.
$0.84HealthcareDelayed quote: Oct 6, 2026, 12:31 PM EDT
PMCB
PharmaCyte Biotech, Inc.
$0.43HealthcareDelayed quote: Oct 6, 2026, 12:59 PM EDT
Total return — BGMS vs PMCB
growth of $100 · dividends reinvested · last 1yBGMS -85.6% (-85.6%/yr)PMCB -62.1% (-62.1%/yr)PMCB compounded faster over this window
BGMS PMCB
BGMS vs PMCB: by the numbers
- •BGMS is the larger company ($5M vs $5M market cap).
- •Both run net losses; PMCB's is the smaller (0.00% vs -118.27% net margin).
Metrics side by side
Valuation
| Metric | BGMS | PMCB |
|---|---|---|
| P/S ratio | 2.49 | N/A |
| P/B ratio | 0.65 | 0.16 |
Profitability
| Metric | BGMS | PMCB |
|---|---|---|
| Gross margin | 19.34% | 0.00% |
| Operating margin | -1128.11% | 0.00% |
| Net margin | -118.27% | 0.00% |
| ROE | -30.74% | -54.15% |
| ROIC | -38.23% | -19.51% |
Growth (annualized)
| Metric | BGMS | PMCB |
|---|---|---|
| Total return CAGR (5Y) | N/A | -33.59% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.